-
抗体試薬
- フローサイトメトリー用試薬
-
ウェスタンブロッティング抗体試薬
- イムノアッセイ試薬
-
シングルセル試薬
- BD® OMICS-Guard Sample Preservation Buffer
- BD® OMICS-One Protein Panels
- BD® AbSeq Assay
- BD® Single-Cell Multiplexing Kit
- BD Rhapsody™ ATAC-Seq Assays
- BD Rhapsody™ Whole Transcriptome Analysis (WTA) Amplification Kit
- BD Rhapsody™ TCR/BCR Next Multiomic Assays
- BD Rhapsody™ Targeted mRNA Kits
- BD Rhapsody™ Accessory Kits
- BD® OMICS-One Immune Profiler Protein Panel
-
細胞機能評価のための試薬
-
顕微鏡・イメージング用試薬
-
細胞調製・分離試薬
Old Browser
Looks like you're visiting us from {countryName}.
Would you like to stay on the current location site or be switched to your location?
BD™ Stem Cell Control CD34+ Whole Blood Process Control
Regulatory Statusの凡例
Becton, Dickinson and Companyの書面による明示的な許諾を得た使用以外での製品の使用は固く禁じられています。
説明
The BD™ Stem Cell control is intended as a complete, two-level, process control for immunophenotyping and enumeration of leucocytes by flow cytometry. It is a control for antibody staining, red blood cell (RBC) lysis, instrument setup and performance, and data analysis.
調製と保管
• Store vials upright, tightly capped, at 2°C to 8°C when not in use.
• Unopened vials are stable until the expiration date indicated on each vial and assay sheet.
• Opened vials are stable for 12 thermal cycles (uses) when handled properly. A thermal cycle constitutes performing all steps under Section 5, Instructions for Use, once.
• Avoid unnecessary cycles of warming and cooling. Protect this product from freezing, from temperatures above 30°C, and from prolonged time at room temperature (18°C to 26°C). Follow exactly the steps in Section 5 Instructions For Use.
| 説明 | 数量/容量 | Part Number | EntrezGene ID |
|---|---|---|---|
| N/A | 2.0 | N/A | N/A |
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.